EFTA01521651.pdf

M IIIIII= a r fJal m- ilM GHISLAINE MAXWELL nett. the Period 5/1/13 to 5131/13 Account Summary Beginning Ending Change Estimated Current Asset Allocation Asset Allocation Market Value Market Value In Value Annual Income Allocation Equity 723,327.40 729,527.64 6,200.24 45,721.83 18% Alternative Assets 70,310.77 66,395.85 (3,914.92) 2% Other Cash 8 Fixed Income 9,641,596.31 3,400,529.80 (6.241,066.51) 44.061.41 77% Other 157,864.00 152.118.61 (5.745.39) 3% Alternative Agars Market Value S10,693,098.48 84.348.571.90 (86.244.526.58) $89,783.24 100% Accruals 25,092.69 23,635 03 (1 457 66) cases Fixed Interne Market Value with Accruals $10,818,191.17 $4.372.206.93 (36.246.984.24) Current Year•to•Date Portfolio Activity Period Value Value Beginning Market Value 10,693,098.48 8,349,268.16 Withdrawals 8 Fees (268.54) (4,001,156.64) Securities Transferred In 1,308,253.29 6,299,937.54 Securities Transferred Out (1,633,528.98) (7,180,085.09) Net Contributions/Withdrawals ($326,644.21) ($4,881,304.19) Income 8 Distributions 6,533.59 40,079.39 Change In Investment Value (5.925,515.96) 840,538.54 Ending Market Value $4,348,571.90 $4,348,571.90 Accruals 23 635.03 23 635.03 Market Value with Accruals $4,372,206.93 34,372,206.93 JP Morgan Page 2 of 28 Confidential Treatment Requested by JPMorgan JPM-SDNY-00049063 Chase CONFIDENTIAL SDNY_GM_00318261 EFTA01521651